Ieramilimab (LAG525) is a humanized antibody targeting LAG-3 with potential anticancer activity, blocking its interaction with MHC-II molecules by binding to LAG-3.Pranlukast hemihydrate can be used to study malignant tumors.
Purity:
96.40%
Target:
LAG-3
* VAT and and shipping costs not included. Errors and price changes excepted
